INSIGHTS ON CLINICAL TRIAL PARTNERING

• How RFI/RFP Optimization Changes The Game

  Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.

• The Ten Commandments Of Vendor Selection

  Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.

• Local-Language Support For Clinical Trial Participants

  Participants and sites need support that matches their language, local hours, and regional expectations. and Global Patient Liaison teams help to create a more human trial experience.

• Early Phase Oncology Site Network: Benefits Of A Personal Touch

  Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.

• DCTs And Community-Based Research Execution And Compliance

  5/28/2025

  The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.

• Expedite Drug Development With An Integrated CDMO-CRO Model

  2/6/2026

  From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

• Top 10 Global Pharma Company Dramatically Improves Site Payments In Drive To Become Sponsor Of Choice

  10/30/2024

  See how a pharma company reduced investigator payment cycle time by 55% while decreasing their own administrative burden by 90% in this metrics-rich case study.

• Participant Payments: Navigating Modern Studies

  12/18/2024

  To address the challenges of disbursing clinical trial participant payments globally, sponsors need region-specific payment solutions that navigate local laws and banking systems.

• Leading Recruitment With A Strong Alzheimer's Referral Pool

  2/24/2026

  A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.